loadpatents
name:-0.029436826705933
name:-0.013838052749634
name:-0.017328023910522
Gusarova; Viktoria Patent Filings

Gusarova; Viktoria

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gusarova; Viktoria.The latest application filed is for "anti-angptl3 antibodies and uses thereof".

Company Profile
16.13.26
  • Gusarova; Viktoria - Pleasantville NY
  • Gusarova; Viktoria - Tarrytown NY
  • Gusarova; Viktoria - Springfield NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-MSR1 antibodies and methods of use thereof
Grant 11,377,502 - Gromada , et al. July 5, 2
2022-07-05
Anti-angptl3 Antibodies And Uses Thereof
App 20220153825 - SLEEMAN; Mark W. ;   et al.
2022-05-19
Methods For Treating Hyperlipidemia With An Angptl8 Inhibitor And An Angptl3 Inhibitor
App 20220127348 - GROMADA; Jesper ;   et al.
2022-04-28
Methods For Treating Or Preventing Atherosclerosis By Administering An Inhibitor Of Angptl3
App 20220089711 - GROMADA; Jesper ;   et al.
2022-03-24
Bis-octahydrophenanthrene Carboxamide Derivatives And Protein Conjugates Thereof For Use As Lxr Agonists
App 20220080052 - GROMADA; Jesper A. ;   et al.
2022-03-17
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody
Grant 10,995,150 - Sasiela , et al. May 4, 2
2021-05-04
Angptl8 Assay And Uses Thereof
App 20200393470 - GUSAROVA; Viktoria ;   et al.
2020-12-17
Methods For Treating Hyperlipidemia With An Angptl8 Inhibitor And An Angptl3 Inhibitor
App 20200377583 - GROMADA; Jesper ;   et al.
2020-12-03
Methods for Treating Patients with Hyperlipidemia by Administering a PCSK9 Inhibitor in Combination with an ANGPTL3 Inhibitor
App 20200199253 - Gusarova; Viktoria ;   et al.
2020-06-25
Non-Human Animals Comprising a Humanized ASGR1 Locus
App 20200154684 - Mujica; Alexander O. ;   et al.
2020-05-21
Methods For Treating Or Preventing Atherosclerosis By Administering An Inhibitor Of Angptl3
App 20200079841 - GROMADA; Jesper ;   et al.
2020-03-12
Non-human animals having an engineered ANGPTL8 gene
Grant 10,582,702 - Gusarova , et al.
2020-03-10
Methods For Inhibiting Atherosclerosis By Administering An Inhibitor Of Pcsk9
App 20200071422 - Sasiela; William J. ;   et al.
2020-03-05
Anti-msr1 Antibodies And Methods Of Use Thereof
App 20190367631 - Gromada; Jesper ;   et al.
2019-12-05
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
Grant 10,494,442 - Sasiela , et al. De
2019-12-03
Anti-angptl3 Antibodies And Uses Thereof
App 20190315851 - SLEEMAN; Mark W. ;   et al.
2019-10-17
Methods of treating obesity with anti-ANGPTL8 antibodies
Grant 10,442,856 - Gusarova , et al. Oc
2019-10-15
Anti-ANGPTL3 antibodies and uses thereof
Grant 10,358,487 - Sleeman , et al. July 23, 2
2019-07-23
Anti-ANGPTL8 antibodies and uses thereof
Grant 10,259,870 - Gusarova , et al.
2019-04-16
Anti-angptl3 Antibodies And Uses Thereof
App 20190092845 - SLEEMAN; MARK W. ;   et al.
2019-03-28
Methods For Inhibiting Atherosclerosis By Administering An Inhibitor Of Pcsk9
App 20180244801 - Sasiela; William J. ;   et al.
2018-08-30
Methods of Treating Obesity with Anti-ANGPTL8 Antibodies
App 20180134781 - Gusarova; Viktoria ;   et al.
2018-05-17
Anti-ANGPTL3 antibodies and uses thereof
Grant 9,951,127 - Sleeman , et al. April 24, 2
2018-04-24
Methods for Treating Hyperlipidemia with an ANGPTL8 Inhibitor and an ANGPTL3 Inhibitor
App 20170291937 - Gromada; Jesper ;   et al.
2017-10-12
Methods for Treating Patients with Hyperlipidemia by Administering a PCSK9 Inhibitor in Combination with an ANGPTL3 Inhibitor
App 20170253666 - Gusarova; Viktoria ;   et al.
2017-09-07
Non-human Animals Having A Engineered Angptl8 Gene
App 20170245481 - Gusarova; Viktoria ;   et al.
2017-08-31
Methods for Treating or Preventing Atherosclerosis by Administering an Inhibitor of ANGPTL3
App 20170233466 - Gromada; Jesper ;   et al.
2017-08-17
Anti-angptl8 Antibodies And Uses Thereof
App 20170037124 - Gusarova; Viktoria ;   et al.
2017-02-09
Methods For Inhibiting Atherosclerosis By Administering An Inhibitor Of Pcsk9
App 20160115246 - Sasiela; William J. ;   et al.
2016-04-28
Human antibodies to human angiopoietin-like protein 4
Grant 9,120,851 - Sleeman , et al. September 1, 2
2015-09-01
Anti-ANGPTL3 Antibodies and Uses Thereof
App 20150197564 - Sleeman; Mark W. ;   et al.
2015-07-16
Anti-ANGPTL3 antibodies and uses thereof
Grant 9,018,356 - Sleeman , et al. April 28, 2
2015-04-28
Human Antibodies To Human Angiopoietin-like Protein 4
App 20130266574 - SLEEMAN; Mark W. ;   et al.
2013-10-10
Anti-ANGPTL3 Antibodies and Uses Thereof
App 20130171149 - Sleeman; Mark W. ;   et al.
2013-07-04
Human antibodies to human angiopoietin-like protein 4
Grant 8,354,103 - Sleeman , et al. January 15, 2
2013-01-15
Human Antibodies To Human Angiopoietin-like Protein 4
App 20110159015 - SLEEMAN; Mark W. ;   et al.
2011-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed